The aim of the study was to provide insights into the contributions of HIV infection stage, antiretroviral therapy (ART) and vascular risk factors to the occurrence of ischaemic stroke in HIV-infected patients.
Introduction
In the HIV-infected population, ischaemic cerebral events, including ischaemic stroke and transient ischaemic attacks (TIAs), have mainly been investigated in younger patients with AIDS before the implementation of antiretroviral therapy (ART) [1, 2] . The most common identified culprits responsible for ischaemic stroke and TIAs were infections, vasculopathy and prothrombotic status [1] [2] [3] .
HIV-infected patients are now ageing [4, 5] . In addition to HIV infection, traditional vascular risk factors and ART toxicity may contribute to the risk of ischaemic stroke [6, 7] . As a consequence, HIV infection and its treatment as well as its interaction with vascular risk factors may contribute to the cause of stroke and affect its clinical presentation and management [8] .
Our main objective was to provide insights into the contributions of HIV infection stage, ART and vascular risk factors to the occurrence of ischaemic stroke or TIA in ageing HIV-infected patients.
Patients and methods
We conducted a single-centre retrospective case-control study of HIV-infected patients followed in the HIV Clinic at Centro Hospitalar São João (Porto, Portugal). We included all patients over 18 years old with a first-ever ischaemic stroke or TIA diagnosed between January 2006 and June 2014. All the patients must have been evaluated by a neurologist or stroke specialist and must have had an image (cerebral computed tomography or magnetic resonance imaging) reported by a neuroradiologist in the acute phase. Potential ischaemic strokes or TIAs were identified in our hospital database according to the International Classification of Diseases ninth edition (ICD9) [ischaemic stroke (ICD9: 433, 434 or 436) and TIA (ICD9: 435)]. The data from clinical records were collected during the second semester of 2014. Patients' files including clinical records were revised by a neurologist in order to classify according the Oxfordshire classification [9] , the National Institutes of Health Stroke Scale (NIHSS) [10] , the ABCD2 classification for TIA [11, 12] and the modified Rankin scale [13] . Neuroimaging, cranial and cervical Doppler ultrasound, echocardiogram, Holter monitoring and other laboratory or imaging assessments required in the evaluation of the stroke were used to classify ischaemic stroke and TIA aetiologically according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria [14] .
The controls (1:1 matched on age and gender) were HIV-infected patients randomly selected from our HIV clinic (from a total of 2146 patients), without precedent stroke or TIA. Subsequent to enrolment of a case, eligible control patients (same gender and age) were alphabetically ordered; an internet-based randomizer (www. randomizer.org) automatically selected a control.
We considered event a stroke evaluation in the emergency department for cases and the end of the study (June 2014) for controls.
We collected clinical, social and demographic data from the clinical records. Previous vascular risk factors [arterial hypertension, dyslipidaemia, diabetes mellitus and smoking (previous or current)] and HIV-related variables [risk factor for HIV acquisition, Centers for Disease Control and Prevention (CDC) HIV staging, number of years of known infection, number and subtypes of ART regimens, cumulative time on each ART regimen and treatment compliance] were evaluated. Laboratory data were also collected: total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, CD4 count nadir, and CD4 count and viral load at the time of the event. We assessed compliance through viral suppression or viraemia when the patient was on ART. We defined a nondetectable viral load below 20 HIV-1 RNA copies/mL (the lower threshold of viral load detection during the study period) in performing the statistical analysis.
The research protocol was approved by the hospital ethics committee.
Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) version 22 (IBM). Categorical data are presented as absolute number and relative frequency, and quantitative data are presented as the appropriate measures of central tendency and dispersion [mean and standard deviation (SD) if normally distributed and median and interquartile range (IQR) if not normally distributed]. We used the following statistical tests: Pearson's chi-squared test (for categorical variables), the independent t-test (for parametric continuous variables), the Mann-Whitney U-test (for nonparametric independent-samples continuous variables) and the Wilcoxon signed rank test (for nonparametric related-samples continuous variables). Two-sided P-values < 0.05 were considered statistically significant.
Results
Among the 2146 patients followed in our HIV clinic, we identified 23 HIV-1-infected patients (20 men and three women) who had a first-ever acute ischaemic cerebral event (82.6% stroke and 17.4% TIA). The mean age was 51.26 years (SD 13.85 years). The median admission NIHSS was 6.50 (IQR 11). Two patients underwent thrombolysis (clinically, both had total anterior circulation stroke caused by large-artery atherosclerosis; one made a full and one a partial recovery, with no adverse events). Comparing the modified Rankin scale on discharge with that on admission, we found a higher score on discharge (P = 0.007; Wilcoxon signed rank test). Three patients died after admission to the hospital (mortality rate 13%; one had malignant middle cerebral artery infarction, and two had infectious complications). Ischaemic cerebral event classifications are presented in Table 1 . Eight patients presented with a clinical lacunar syndrome, five patients with a total anterior circulation syndrome and the remaining with partial anterior circulation syndromes and posterior circulation syndromes (three each). The aetiology of stroke based on the TOAST classification showed a high prevalence of small-vessel occlusion (seven patients), followed by large-artery atherosclerosis and cardioembolism (four each). Two patients were classified as having other determined aetiology: endocarditis and vasculopathy associated with the use of cocaine. Six patients were classified as having an undetermined aetiology: five with an incomplete evaluation and one with a negative evaluation.
Regarding HIV infection (Table 2) , the median CD4 cell count of the cases at the time of the acute ischaemic cerebral event was 273.50 cells/lL (IQR 273.25 cells/lL). However, 32% were severely immunosuppressed (CD4 count < 200 cells/lL) and 50% were moderately immunosuppressed (CD4 count between 200 and 500 cells/lL). The median viral load at the time of the event was undetectable (IQR 127 copies/mL). The cases had lower CD4 counts (P = 0.001; Mann-Whitney U-test), were more immunosuppressed (P = 0.022; Pearson's v 2 test) and had higher viral loads (P = 0.011; MannWhitney U-test) than the controls. There were statistically significant differences between the cases and controls regarding the risk factor for acquiring HIV (P = 0.038; Pearson's v 2 test). In the cases, there were more injecting drug users and fewer patients with a heterosexual risk. There were also statistically significant differences in the active use of drugs: there were higher numbers of active consumers of cocaine (P = 0.036; Pearson's v 2 test) and heroin (P = 0.009; Pearson's v 2 test) in cases. In contrast, there were no statistically significant differences between the two groups in CDC HIV staging (P = 0.107; Pearson's v 2 test), CD4 count nadir (P = 0.331; Mann-Whitney U-test) and HIV infection cumulative time-to-event (P = 0.154; independent t-test).
Regarding ART (Table 3) , there were no statistically significant differences between cases and controls in the following parameters: number of ART regimens (P = 0.644; Mann-Whitney U-test), treatment compliance (P = 0.769; Pearson's v 2 test) or ART time-to-event (P = 0.070; Mann-Whitney U-test). There was also no statistically significant difference in the time-to-event of each pharmacological group (nucleoside/nucleotide reverse transcriptase inhibitors, nonnucleoside/nucleotide reverse transcriptase inhibitors, protease inhibitors or integrase inhibitors; Mann-Whitney U-test).
With regard to vascular risk factors (Table 4) , we found statistically significant differences between cases and controls in the frequencies of diabetes and smoking and in the concentration of HDL cholesterol. Diabetes was more frequent in the cases (P = 0.009; Pearson's v 2 test), 
Discussion
In our case-control study, we found associations of previous or current illegal drug consumption, uncontrolled HIV infection and some traditional vascular risk factors with the occurrence of acute ischaemic cerebral events in HIVinfected patients. No association was found with ART.
The application of the Oxfordshire classification of stroke revealed a higher prevalence of patients with lacunar syndromes than found in some other studies in HIV-infected and HIV-uninfected patients. Tipping et al.
[15] carried out a study in 64 HIV-infected patients with ischaemic stroke from South Africa and concluded that the most frequent presentation was partial anterior circulation syndrome followed by lacunar stroke. Similar findings were obtained when this classification was applied to HIV-uninfected patients [9] . The discrepancies between these findings and our results may be explained by our cases having a lower median age, a higher prevalence of diabetes and a lower prevalence of cardioembolism.
Small-vessel occlusion was the most frequent aetiology of stroke in our cases. Cardioembolism and large-artery atherosclerosis were the second most frequent aetiology. Several other studies have addressed the aetiology of ischaemic stroke in HIV-infected patients. Ortiz et al. [16] obtained similar results, with small-vessel occlusion and cardioembolism as the leading causes of stroke. Nevertheless, other studies found large-artery atherosclerosis to be the main causal factor, followed by small-vessel occlusion [17] [18] [19] . The prevalence of undetermined aetiologies varied from 10 to 32% in the different studies [16] [17] [18] [19] . Despite the application of transcranial and cervical Doppler ultrasound in the majority of patients (n = 20), the number of patients with stroke caused by large-artery atherosclerosis was lower in our study. In the comparison between our HIV-infected patients with ischaemic stroke and those without stroke, we observed a higher prevalence of vascular risk factors, including hypertension, diabetes, dyslipidaemia and smoking, in the patients with ischaemic stroke. Diabetes, smoking and low HDL levels were more prevalent in the HIV-infected patients with stroke, which may explain the aetiological distribution of stroke in our study. Few studies have compared vascular risk factors in HIV-infected patients with and without stroke. Chow et al. [19] demonstrated a high prevalence of hypertension, dyslipidaemia and smoking. Hypertension and dyslipidaemia were associated with higher ischaemic stroke odds in unadjusted analyses [19] . Another study [17] also found a higher prevalence of vascular risk factors in patients with stroke, but only smoking showed a statistically significant difference between patients with and without stroke.
The HIV-infected patients with stroke were more severely immunosuppressed, with lower CD4 counts and higher HIV viral load. CD4 count nadir and ART seemed not to influence the risk of stroke. This conclusion is in line with other recent publications in the literature [17, 19] .
Our study has some limitations. It was a single-centre retrospective study with a small number of cases. Because of the low sample size, multivariate analysis was not performed. Bias resulting from missing data is possible; nevertheless, stroke misclassification was overcome by the There is a scarcity of studies in the literature comparing HIV-infected patients with and without stroke. Only by comparing two samples of patients exposed to HIV infection can we address specific factors responsible for stroke in the HIV-infected population.
The reason why HIV replication causes stroke is not known. Interactions between HIV, ART, illegal drugs, coinfections, opportunistic infections and vascular risk factors are very complex and hard to analyse [8] . Our study provides insights into the clinical and aetiological characterization of stroke. It also contributes to elucidation of the different factors that may contribute to stroke in the HIV-infected population.
The paradigm of the care of HIV-infected patients is changing. Concomitant diseases in the ageing patient with HIV infection, including cerebrovascular disease, must also be addressed in view of their impact on morbidity and mortality. In addition to controlling HIV infection and immunosuppression with ART, vascular risk factors must also be addressed.
